0001398344-13-002556.txt : 20130517 0001398344-13-002556.hdr.sgml : 20130517 20130517160518 ACCESSION NUMBER: 0001398344-13-002556 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130517 DATE AS OF CHANGE: 20130517 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Receptos, Inc. CENTRAL INDEX KEY: 0001463729 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87460 FILM NUMBER: 13855111 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 652-5712 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Receptos, Inc. (f.k.a. Receptor Pharmaceuticals Inc.) DATE OF NAME CHANGE: 20090522 FORMER COMPANY: FORMER CONFORMED NAME: Receptor Pharmaceuticals Inc. DATE OF NAME CHANGE: 20090507 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Lilly Ventures Fund I LLC CENTRAL INDEX KEY: 0001575852 IRS NUMBER: 264769290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 115 W WASHINGTON STREET STREET 2: SUITE 1680 SOUTH CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: (317) 429-0140 MAIL ADDRESS: STREET 1: 115 W WASHINGTON STREET STREET 2: SUITE 1680 SOUTH CITY: INDIANAPOLIS STATE: IN ZIP: 46204 SC 13G 1 fp0007303_sc13g.htm fp0007303_sc13g.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
 
Receptos, Inc.
(Name of Issuer)
 
Common Stock; $0.001 par value
(Title of Class of Securities)
 
756207106
(CUSIP Number)

May 14, 2013
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
 
[   ]
Rule 13d-1(b)
 
[X]
Rule 13d-1(c)
 
[   ]
Rule 13d-1(d)
 
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing of this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
 
 
 
 
 
CUSIP No. 756207106
Page 2 of 6
   
1.
Name of Reporting Person
 
I.R.S. Identification No. of Above Person  (Entities Only)
     
 
Lilly Ventures Fund I, LLC
26-4769290
     
2.
Check the Appropriate Box if a Member of a Group
       
       
(a) ____
     
(b) ____
     
3.
SEC Use Only
     
     
     
4.
Citizenship or Place of Organization
     
 
Delaware
     
   
5.
Sole Voting Power
       
Number of
  
0
Shares
    
Beneficially
6.
Shared Voting Power
Owned By
    
Each Reporting
  
2,081,210
Person with
    
   
7.
Sole Dispositive Power
       
     
0
       
   
8.
Shared Dispositive Power
       
     
2,081,210
       
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
     
 
2,081,210
     
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares
     
 
[ ]
     
11.
Percent of Class Represented by Amount in Row (9)
     
 
11.8%
   
12.
Type of Reporting Person
     
 
OO
     
 
 
 
 

CUSIP No. 756207106
Page 3 of 6
     
1.
Name of Reporting Person
  
 
I.R.S. Identification No. of Above Person  (Entities Only)
  
         
 
S. Edward Torres
  
         
2.
Check the Appropriate Box if a Member of a Group
  
         
       
(a) ____
       
(b) ____
         
3.
SEC Use Only
  
         
         
         
4.
Citizenship or Place of Organization
  
         
 
United States of America
  
         
   
5.
Sole Voting Power
  
         
Number of
  
0
  
Shares
      
Beneficially
6.
Shared Voting Power
  
Owned By
      
Each Reporting
  
2,081,210
  
Person with
      
   
7.
Sole Dispositive Power
  
         
     
0
  
         
   
8.
Shared Dispositive Power
  
         
     
2,081,210
  
         
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
  
     
 
2,081,210
  
         
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares
  
         
 
[_]
      
         
11.
Percent of Class Represented by Amount in Row (9)
  
         
 
11.8%
      
         
12.
Type of Reporting Person
  
         
 
IN
      
         

 
 
 

CUSIP No. 756207106
Page 4 of 6

Item 1(a)
Name of Issuer

Receptos, Inc.

Item 1(b)
Address of Issuer’s Principal Executive Offices

10835 Road to the Cure, Suite 205
San Diego, California 92121
 
Item 2(a)
Name of Person Filing

Lilly Ventures Fund I, LLC
S. Edward Torres. Mr. Torres is a non-managing member of Lilly Ventures Fund I, LLC.

Item 2(b)
Address of Principal Business Office, or if none, Residence

115 West Washington St.
Suite 1680-South
Indianapolis, IN 46204
 
Item 2(c)
Citizenship
 
Lilly Ventures Fund I, LLC is a limited liability company organized under the laws of the State of Delaware. Mr. Torres is a United States citizen.
 
Item 2(d)
Title of Class of Securities
 
Common Stock
 
Item 2(e)
CUSIP Number
 
756207106

Item 3.
Filing pursuant to Rules 13d-1(b) or 13d-2(b) or (c)

Not Applicable
 
 
 
 
 
CUSIP No. 756207106
Page 5 of 6
 
Item 4.
Ownership

This Schedule 13G shall not be construed as an admission that any Reporting Person is, either for purposes of Section 13(d) or 13(g) of the Securities Exchange Act or for other purposes, the beneficial owner of any Common Stock disclosed on this Schedule 13G.

 
(a)
Amount Beneficially Owned:

As of the date hereof, Lilly Ventures Fund I, LLC owns beneficially and of record 2,081,210 shares of Common Stock of Receptos, Inc. Mr. Torres is a non-managing member of Lilly Ventures Fund I, LLC and therefore may be deemed to beneficially own the shares beneficially owned by Lilly Ventures Fund I, LLC.

Mr. Torres disclaims beneficial ownership of the shares held of record by Lilly Ventures Fund I, LLC, except to the extent of his pecuniary interest therein.

 
(b)
Percent of Class:

Lilly Ventures Fund I, LLC and Mr. Torres may each be deemed to beneficially own 11.8% of the Common Stock of Receptos, Inc.

 
(c)
Number of shares as to which the person has:
 
(i)
sole power to vote or to direct the vote:
 
a.
Lilly Ventures Fund I, LLC: 0; and
 
b.
S. Edward Torres: 0.
 
(ii)
shared power to vote or to direct the vote:
 
a.
Lilly Ventures Fund I, LLC: 2,081,210; and
 
b.
S. Edward Torres: 2,081,210.
 
(iii)
sole power to dispose or to direct the disposition of:
 
a.
Lilly Ventures Fund I, LLC: 0; and
 
b.
S. Edward Torres: 0.
 
(iv)
shared power to dispose or to direct the disposition of:
 
a.
Lilly Ventures Fund I, LLC: 2,081,210; and
 
b.
S. Edward Torres: 2,081,210.

Item 5.
Ownership of Five Percent or Less of a Class

Not Applicable

Item 6.
Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not Applicable

Item 8.
Identification and Classification of Members of the Group

Not Applicable

Item 9.
Notice of Dissolution of Group

Not Applicable

Item 10.
Certification

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 
 
CUSIP No. 756207106
Page 6 of 6

SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date:
May 16, 2013

 
LILLY VENTURES FUND I, LLC
  
       
 
By:
/s/ S. Edward Torres
  
 
Name:
S. Edward Torres
  
 
Title:
Non-Managing Member
  
       
 
/s/ S. Edward Torres
  
 
S. Edward Torres
  
 
This filing is made voluntarily and should not be construed as an admission that the reporting persons are subject to reporting requirements under Section 13 of the Securities Exchange Act of 1934.